1
|
Kumar M, Pettinato A, Ladha F, Earp JE, Jain V, Patil S, Engelman DT, Robinson PF, Moumneh MB, Goyal P, Damluji AA. Sarcopenia and aortic valve disease. Heart 2024; 110:974-979. [PMID: 38649264 PMCID: PMC11236523 DOI: 10.1136/heartjnl-2024-324029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/16/2024] [Accepted: 04/02/2024] [Indexed: 04/25/2024] Open
Abstract
Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Despite improvements in outcomes, older adults with competing comorbidities and geriatric syndromes have suboptimal quality of life outcomes, highlighting the cumulative vulnerability that persists despite valve replacement. Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%-70% of older adults with AS. Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning. Early diagnosis and treatment of sarcopenia may reduce morbidity and mortality and improve quality of life following TAVR. The adverse effects of sarcopenia can be mitigated through resistance training and optimisation of nutritional status. This is most efficacious when administered before sarcopenia has progressed to advanced stages. Management should be individualised based on the patient's wishes/preferences, care goals and physical capability. Exercise during the preoperative waiting period may be safe and effective in most patients with severe AS. However, future studies are needed to establish the benefits of prehabilitation in improving quality of life outcomes after TAVR procedures.
Collapse
Affiliation(s)
| | | | - Feria Ladha
- Boston Children's Hospital, Boston, Massachusetts, USA
| | - Jacob E Earp
- University of Connecticut, Storrs, Connecticut, USA
| | - Varun Jain
- Trinity Health of New England, Hartford, Connecticut, USA
| | - Shivaraj Patil
- Albert Einstein College of Medicine, Bronx, New York, USA
| | | | | | | | - Parag Goyal
- Division of General Internal Medicine, Weill Cornell Medicine, New York, New York, USA
- Division of Cardiovascular Medicine, Weill Cornell Medicine, New York, New York, USA
| | - Abdulla A Damluji
- Johns Hopkins University, Baltimore, Maryland, USA
- Inova Health System, Falls Church, Virginia, USA
| |
Collapse
|
2
|
Suen WL, Bhasin S, Betti V, Bruckel JT, Oldham MA. Mental health and transcatheter aortic valve replacement: A scoping systematic review. Gen Hosp Psychiatry 2024; 86:10-23. [PMID: 38043178 PMCID: PMC10842766 DOI: 10.1016/j.genhosppsych.2023.11.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 11/22/2023] [Accepted: 11/23/2023] [Indexed: 12/05/2023]
Abstract
OBJECTIVE To systematically review the literature on mental health symptoms before and after transcatheter aortic valve replacement (TAVR) and describe reported clinical associations with these symptoms. METHODS Using the Preferred Reporting Items for Systematic reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) guidelines, we reviewed studies involving pre- or post-TAVR mental health assessments or psychiatric diagnoses. RESULTS Eighteen studies were included. Before TAVR, clinically significant depression and anxiety prevalence is 15-30% and 25-30%, respectively, with only a third of these meeting diagnostic thresholds. These symptoms generally improve over the year post-TAVR. Depression is associated with functional impairment, multimorbidity, and lower physical activity; few associations have been described in relation to anxiety. Inconsistent evidence finds depression associated with post-TAVR mortality. One notable study found persistent depression independently predictive of 12-month mortality, and another found depression and cognition to have additive value in predicting mortality risk. CONCLUSIONS Mental health symptoms occur in a significant proportion of the TAVR population. Although symptoms tend to improve, the associations with depression, particularly persistent depression, call for further investigation to examine their associated outcomes. Research is also needed to understand the relationships between mental health conditions and cognition in TAVR-related outcomes.
Collapse
Affiliation(s)
- Wei-Li Suen
- Department of Psychiatry, University of Rochester Medical Center, USA
| | - Shreya Bhasin
- School of Medicine & Dentistry, University of Rochester Medical Center, USA
| | - Vincent Betti
- School of Medicine & Dentistry, University of Rochester Medical Center, USA
| | | | - Mark A Oldham
- Department of Psychiatry, University of Rochester Medical Center, USA.
| |
Collapse
|
3
|
Vankayalapati DK, Segun-Omosehin O, El Ghazal N, Suresh Daniel R, El Haddad J, Mansour R, Yap N, Miangul S, Nakanishi H, Than CA. Long-Term Outcomes of Mechanical Versus Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Cureus 2024; 16:e52550. [PMID: 38371071 PMCID: PMC10870098 DOI: 10.7759/cureus.52550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/19/2024] [Indexed: 02/20/2024] Open
Abstract
This study aimed to investigate the safety and efficacy of bioprosthetic (BV) versus mechanical valves (MV) on long-term outcomes in 50- to 70-year-old aortic stenosis (AS) patients. A literature search for articles published until April 2023 yielded 13 eligible studies, with 15,320 patients divided into BV (n = 7,320) and MV (n = 8,000) cohorts. The review was registered prospectively with PROSPERO (CRD42021278777). MV demonstrated a favorable hazard ratio (HR: 1.12, 95% CI: 1.00-1.25, I2 = 60%) and higher survival rates at 5 (OR:1.13, 95% CI: 1.02-1.25, I2 = 42%) and 10 years (OR: 1.13, 95% CI: 1.05-1.23, I2 = 0%). At 15 years, stroke incidence was comparable (OR: 1.12, 95% CI: 0.98-1.27, I2 = 4%). BV showed lower bleeding events (OR: 1.7, 95% CI: 1.18-2.46, I2 = 88%), but MV replacement showed lower reoperation incidence (OR: 0.27, 95% CI: 0.18-0.42, I2 = 85%). MV appears favorable for the long-term approach in AS management compared to BV.
Collapse
Affiliation(s)
| | - Omotayo Segun-Omosehin
- Cardiothoracic Surgery, St George's University of London, London, GBR
- Cardiothoracic Surgery, University of Nicosia Medical School, Nicosia, CYP
| | - Nour El Ghazal
- Cardiothoracic Surgery, St George's University of London, London, GBR
- Cardiothoracic Surgery, University of Nicosia Medical School, Nicosia, CYP
| | - Rohan Suresh Daniel
- Cardiothoracic Surgery, St George's University of London, London, GBR
- Cardiothoracic Surgery, University of Nicosia Medical School, Nicosia, CYP
| | - Joe El Haddad
- Cardiothoracic Surgery, St George's University of London, London, GBR
- Cardiothoracic Surgery, University of Nicosia Medical School, Nicosia, CYP
| | - Rania Mansour
- Cardiothoracic Surgery, St George's University of London, London, GBR
- Cardiothoracic Surgery, University of Nicosia Medical School, Nicosia, CYP
| | - Nathanael Yap
- Cardiothoracic Surgery, St George's University of London, London, GBR
- Cardiothoracic Surgery, University of Nicosia Medical School, Nicosia, CYP
| | - Shahid Miangul
- Cardiothoracic Surgery, St George's University of London, London, GBR
- Cardiothoracic Surgery, University of Nicosia Medical School, Nicosia, CYP
| | - Hayato Nakanishi
- Cardiothoracic Surgery, St George's University of London, London, GBR
- Cardiothoracic Surgery, University of Nicosia Medical School, Nicosia, CYP
| | - Christian A Than
- Biomedical Sciences, The University of Queensland, Brisbane, AUS
| |
Collapse
|
4
|
Fradejas-Sastre V, Parás-Bravo P, Herrero-Montes M, Paz-Zulueta M, Boixadera-Planas E, Fernández-Cacho LM, Veiga-Fernández G, Arnáiz-García ME, De-la-Torre-Hernández JM. Surgical vs. transcatheter aortic valve replacement in patients over 75 years with aortic stenosis: sociodemographic profile, clinical characteristics, quality of life and functionality. PeerJ 2023; 11:e16102. [PMID: 37780383 PMCID: PMC10538279 DOI: 10.7717/peerj.16102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Accepted: 08/25/2023] [Indexed: 10/03/2023] Open
Abstract
Background Aortic valve stenosis (AVS) affects 25% of the population over 65 years. At present, there is no curative medical treatment for AVS and therefore the surgical approach, consisting of transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR), is the treatment of choice. Methodology The aim of this study was to analyze the sociodemographic and clinical characteristics, quality of life and functionality of a sample of patients with AVS over 75 years of age, who underwent TAVR or SAVR, applying standard clinical practice. A prospective multicenter observational study was conducted in two hospitals of the Spanish National Health System. Data were collected at baseline, 1, 6 months and 1 year. Results In total, 227 participants were included, with a mean age of 80.6 [SD 4.1]. Statistically significant differences were found in terms of quality of life, which was higher at 1 year in patients who underwent SAVR. In terms of functionality, SAVR patients obtained a better score (p < 0.01). However, patients who underwent TAVR began with a worse baseline situation and managed to increase their quality of life and functionality after 1 year of follow-up. Conclusion The individualized choice of TAVR or SAVR in patients with AVS improves patients' quality of life and function. Moreover, the TAVR procedure in patients with a worse baseline situation and a high surgical risk achieved a similar increase in quality of life and functionality compared to patients undergoing SAVR with a better baseline situation.
Collapse
Affiliation(s)
- Víctor Fradejas-Sastre
- Nursing Department, Universidad de Cantabria, Santander, Cantabria, Spain
- Interventional Cardiology and Hemodynamics Unit, Hospital Universitario Marqués de Valdecilla, Spain, Santander, Cantabria, Spain
- Research Group in Cardiovascular, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain
| | - Paula Parás-Bravo
- Nursing Department, Universidad de Cantabria, Santander, Cantabria, Spain
- Nursing Research Group, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain
| | - Manuel Herrero-Montes
- Nursing Department, Universidad de Cantabria, Santander, Cantabria, Spain
- Nursing Research Group, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain
| | - María Paz-Zulueta
- Nursing Department, Universidad de Cantabria, Santander, Cantabria, Spain
- Research Group in Health Law and Bioethics, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain
| | - Ester Boixadera-Planas
- Servei d’Estadística Aplicada, Universidad Autonoma de Barcelona, Barcelona, Cataluña, Spain
| | | | - Gabriela Veiga-Fernández
- Interventional Cardiology and Hemodynamics Unit, Hospital Universitario Marqués de Valdecilla, Spain, Santander, Cantabria, Spain
- Research Group in Cardiovascular, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain
| | - Maria Elena Arnáiz-García
- Cardiac Surgery Service, Hospital Universitario de Salamanca, Spain, Salamanca, Castilla y Leon, Spain
| | - Jose María De-la-Torre-Hernández
- Interventional Cardiology and Hemodynamics Unit, Hospital Universitario Marqués de Valdecilla, Spain, Santander, Cantabria, Spain
- Research Group in Cardiovascular, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Cantabria, Spain
| |
Collapse
|
5
|
Frank D, Kennon S, Bonaros N, Romano M, Di Mario C, van Ginkel DJ, Bor W, Kasel M, De Backer O, Hachaturyan V, Lüske CM, Kurucova J, Bramlage P, Styra R. Quality of Life Measures in Aortic Stenosis Research: A Narrative Review. Cardiology 2023; 148:556-570. [PMID: 37442111 PMCID: PMC10733944 DOI: 10.1159/000531465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2022] [Accepted: 05/31/2023] [Indexed: 07/15/2023]
Abstract
BACKGROUND Elderly patients with aortic stenosis (AS) not only have a reduced life expectancy but also a reduced quality of life (QoL). The benefits of an AS intervention may be considered a balance between a good QoL and a reasonably extended life. However, the different questionnaires being used to determine the QoL were generally not developed for the specific situation of patients with AS and come with strengths and considerable weaknesses. The objective of this article was to provide an overview of the available QoL instruments in AS research, describe their strengths and weaknesses, and provide our assessment of the utility of the available scoring instruments for QoL measurements in AS. SUMMARY We identified and reviewed the following instruments that are used in AS research: Short Form Health Survey (SF-36/SF-12), EuroQol-5D (EQ-5D), the Illness Intrusiveness Rating Scale (IIRS), the HeartQoL, the Kansas City Cardiomyopathy Questionnaire (KCCQ), the Minnesota Living with Heart Failure Questionnaire (MLHF), the MacNew Questionnaire, and the Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ). KEY MESSAGES There is no standardized assessment of QoL in patients with AS. Many different questionnaires are being used, but they are rarely specific for AS. There is a need for AS-specific research into the QoL of patients as life prolongation may compete for an improved QoL in this elderly patient group.
Collapse
Affiliation(s)
- Derk Frank
- Department of Internal Medicine III (Cardiology, Angiology and Critical Care), UKSH University Clinical Center Schleswig-Holstein and DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, Kiel, Germany
| | - Simon Kennon
- Department of Cardiology, Barts Heart Centre, St. Bartholomew’s Hospital, London, UK
| | - Nikolaos Bonaros
- Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria
| | - Mauro Romano
- Department of Thoracic and Cardiovascular Surgery, Department of Interventional Cardiology, Hôpital Privé Jacques Cartier, Massy, France
| | - Carlo Di Mario
- Structural Interventional Cardiology, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy
| | - Dirk-Jan van Ginkel
- Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
| | - Wilbert Bor
- Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
| | - Markus Kasel
- Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland
| | - Ole De Backer
- Interventional Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark
| | | | - Claudia M. Lüske
- Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
| | | | - Peter Bramlage
- Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
| | - Rima Styra
- Department of Psychiatry, University Health Network, Toronto, ON, Canada
| |
Collapse
|
6
|
Demystifying the Value of Minimal Clinically Important Difference in the Cardiothoracic Surgery Context. Life (Basel) 2023; 13:life13030716. [PMID: 36983869 PMCID: PMC10056462 DOI: 10.3390/life13030716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Revised: 02/08/2023] [Accepted: 03/01/2023] [Indexed: 03/09/2023] Open
Abstract
The aim of this review is to describe the different statistical methods used in estimating the minimal clinically important difference (MCID) for the assessment of quality of life (QOL)-related and clinical improvement interventions, along with their implementation in cardiothoracic surgery. A thorough literature search was performed in three databases (PubMed/Medline, Scopus, Google Scholar) for relevant articles from 1980 to 2022. We included articles that implemented and assessed statistical methods used to estimate the concept of MCID in cardiothoracic surgery. MCID has been successfully implemented in several medical specialties. Anchor-based and distribution-based methods are the most common approaches when evaluating the MCID. Nonetheless, we found only five studies investigating the MCID in the context of cardiothoracic surgery. Four of them used anchor-based approaches, and one used both anchor-based and distribution-based methods. MCID values were very variable depending on the methods applied, as was the clinical context of the study. The variables of interest were certain QOL measuring questionnaires, used as anchors. Multiple anchors and methods were applied, leading to different estimations of MCID. Since cardiothoracic surgery is related to important perioperative morbidity, MCID might represent an important and efficient adjunct tool to interpret clinical outcomes. The need for MCID methodology implementation is even higher in patients with heart failure undergoing cardiac surgery. More studies are needed to validate different MCID methods in this context.
Collapse
|